Dr Portia Smith provides an update on her fellowship research at the University of Wisconsin- Madison, where she’s developing next-generation CAR T-cell therapies to target aggressive childhood brain cancers.

This three-year project is the first co-funded fellowship between the RCD Foundation and UW–Madison, helping drive global collaboration and push forward innovative treatments for young people with brain cancer.